Suche starten De menü ClientConnect
Suche starten
Ergebnisse
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20200488
    Veröffentlichungsdatum: 9 Oktober 2020

    Projektträger – zwischengeschaltetes Finanzinstitut

    CAPE BIO PHARMS (PTY) LTD

    Ort

    Beschreibung

    The project aims to establish a new plant-based current Good Manufacturing Practice (cGMP)-level manufacturing facility together with related processing laboratories and climate-controlled hydroponic grow rooms to produce reagents for the testing and treatment of COVID-19 and other endemic African diseases (e.g. Ebola, dengue, measles, HIV or yellow fever) in Mauritius. The facility is expected to reach a production capacity equivalent to 100 million test kits and/or vaccines per month.

    Ziele

    The project objective is to finance the establishment of a new state-of-the-art plant-based cGMP manufacturing facility in Mauritius to increase the production of reagents for research and diagnostic applications, vaccines, therapeutics or biosimilar development against COVID-19 and other endemic African diseases (e.g. Ebola, dengue, measles, HIV or yellow fever). The EIB's financing will follow a grant provided by FINDx to the company for the first ramp-up phase of their manufacturing activities. This innovative project intends to support substantial research and product development into areas of high, unmet medical needs by providing reagents to a plethora of diagnostic companies in the field of infectious diseases. The operation supports the control of the spread of COVID-19 as it will increase the supply of COVID-19 specific antigens and antibodies for rapid diagnostic test kits to detect whether the individual is infected with COVID-19, as well as if the individual was infected with the virus, providing critical data to determine how COVID-19 is spreading amongst communities.

    Sektor(en)

    • Industrie - Verarbeitendes Gewerbe/Herstellung von Waren

    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 38 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 48 million

    Umweltaspekte

    The project will be subject to a full Environmental and Social impact Assessment and appropriate measures will be taken to avoid, reduce, mitigate, compensate and remedy the likely impact in order to comply with applicable EIB Environmental and Social Standards.

    Auftragsvergabe

    The Bank will require that the Promoter ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.

    Projektstatus

    Unterzeichnet - 18/12/2020

    Haftungsausschluss

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Tags

    Mauritius Industrie